NFE2L2 and breast cancer: Targeted inhibition of miR-141-3p significantly promoted ferroptosis by modulating the Keap1-Nrf2 signaling pathway in breast cancer cells under paclitaxel treatment, which in turn inhibited paclitaxel resistance in breast cancer cells.